1. An Update on Anti-COVID-19 Vaccines and the Challenges to Protect Against New SARS-CoV-2 Variants.
Mambelli, Fábio; de Araujo, Ana Carolina V. S. C.; Farias, Jéssica P.; de Andrade, Kivia Q.; Ferreira, Luis C. S.; Minoprio, Paola; Leite, Luciana C. C.; Oliveira, Sergio C. Pathogens. 2025 Jan 1;14(1):23. doi: 10.3390/pathogens14010023.
2. Early life microbial succession in the gut follows common patterns in humans across the globe. Fahur Bottino G, Bonham KS, Patel F, McCann S, Zieff M, Naspolini N, Ho D, Portlock T, Joos R, Midani FS, Schüroff P, Das A, Shennon I, Wilson BC, O’Sullivan JM, Britton RA, Murray DM, Kiely ME, Taddei CR, Beltrão-Braga PCB, Campos AC, Polanczyk GV, Huttenhower C, Donald KA, Klepac-Ceraj V.Nat Commun. 2025 Jan 14;16(1):660. doi: 10.1038/s41467-025-56072-w.PMID: 39809768
3. Identifying biomarkers and trajectories of executive functions and language development in the first 3 years of life: Design, methods, and findings of the Germina cohort study. Fatori D, Shephard E, Benette D, Naspolini NF, Guzman GC, Wang JYT, Tótolo P, Mafra AL, Isaias C, Dos Santos DP, Russo FB, Kobayashi G, Argeu A, Teixeira M, Mattiello-Sverzut AC, Fernandes MTB, Petian-Alonso DC, Brentani H, Scliar M, Schüroff PA, Zuccolo P, Lerner R, Geraldini S, Euclydes VLV, Matijasevich A, de Campos AC, de Carvalho ACP, Fujita A, Taddei CR, Passos-Bueno MR, Beltrão-Braga P, Polanczyk GV.Dev Psychopathol. 2025 Mar 5:1-11. doi: 10.1017/S0954579425000069
4. Modeling potential drugs for Zika virus in animal and in vitro platforms: what is the current state of the art? Santos D, Carrijo Oliveira N, Costa ECA, Ramalho Paes MV, Beltrão-Braga B, Castanha AG, Beltrão-Braga PCB.Expert Opin Drug Discov. 2025 May;20(5):585-597. doi: 10.1080/17460441.2025.2496461. Epub 2025 Apr 23.PMID: 40251755 Review.
5. West Nile virus – a re-emerging global threat: recent advances in vaccines and drug Discovery. Kocabiyik, Deren Zehra; Flórez Álvarez, Lizdany; Durigon, Edison Luiz; Wrenger, Carsten. Front Cell Infect Microbio, 2025 May 15:15:1568031. doi: 10.3389/fcimb.2025.1568031. eCollection 2025.
6. P.1 and P.2 SARS-CoV-2 Brazilian variants activate the unfolded protein response with a time and pathway specificity. Gomes, Vinícius de Morais; Santos, Deivid Martins; Macedo-da-Silva, Janaina; Lazari, Lucas C.; Machado, Rafael Rahal Guaragna; Dos Santos, Ancely Ferreira; Araujo, Danielle Bastos; Coutinho, João Vitor Paccini; Arini, Gabriel Santos; Angeli, Claudia B.; de Souza, Edmarcia E.; Marques, Rodolfo F.; Boscardin, Silvia Beatriz; Wrenger, Carsten; Marinho, Claudio Romero Farias; Oliveira, Danielle B. L.; Durigon, Edison L.; Labriola, Leticia; Rosa-Fernandes, Livia; Palmisano, Giuseppe. J Proteomics, 2025 May 15:315:105397. doi: 10.1016/j.jprot.2025.105397.
7. Plant-derived extracts and natural products with antiviral activity. Gomes Ribeiro, Giovane de Jesus; de Souza, Edmarcia Elisa; Palmisano, Giuseppe; Durigon, Edison Luiz; Liebau, Eva; Wrenger, Carsten. Frontiers in Virology. 6 August 2025 – Sec. Antivirals and Vaccines – Volume 5 – 2025 – doi:10.3389/fviro.2025.1632734